Evidence map›Paper›PMID 33447575›Full record

ReviewGland surgery2020

Apparent diffusion coefficient magnetic resonance imaging (ADC-MRI) in the axillary breast cancer lymph node metastasis detection: a narrative review.

Camilla De Cataldo, Federico Bruno, Pierpaolo Palumbo, Alessandra Di Sibio, Francesco Arrigoni, Alfredo Clemente, Alberto Bafile, Giovanni Luca Gravina, Salvatore Cappabianca, Antonio Barile and 3 more

Abstract readReview
In one paragraph

Review in Gland surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Value of magnetic resonance imaging radiomics features in predicting histologic grade of invasive ductal carcinoma of the breast.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Camilla De CataldoDepartment of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Federico BrunoDepartment of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Pierpaolo PalumboDepartment of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Alessandra Di SibioRadiology Unit, San Salvatore Hospital, L'Aquila, Italy.
Francesco ArrigoniDepartment of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Alfredo ClementeDepartment of Precision Medicine, University of Campania "L. Vanvitelli", Naples, Italy.
Alberto BafileBreast Unit, S. Salvatore Hospital, L'Aquila, Italy.
Giovanni Luca GravinaDepartment of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Salvatore CappabiancaDepartment of Precision Medicine, University of Campania "L. Vanvitelli", Naples, Italy.
Antonio BarileDepartment of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Alessandra SplendianiDepartment of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Carlo MasciocchiDepartment of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Ernesto Di CesareDepartment of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of axillary lymph nodes metastases in breast cancer is the most significant prognostic factor, with a great impact on morbidity, disease-related survival and management of oncological therapies; for this reason, adequate imaging evaluation is strictly necessary. Physical examination is not enough sensitive to assess breast cancer nodal status; axillary ultrasonography (US) is commonly used to detect suspected or occult nodal metastasis, providing exclusively morphological evaluation, with low sensitivity and positive predictive value. Currently, sentinel lymph node biopsy (SLNB) and/or axillary dissection are the milestone for the diagnostic assessment of axillary lymph node metastases, although its related morbidity. The impact of magnetic resonance imaging (MRI) in the detection of nodal metastases has been widely investigated, as it continues to represent the most promising imaging modality in the breast cancer management. In particular, diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) values represent additional reliable non-contrast sequences, able to improve the diagnostic accuracy of breast cancer MRI evaluation. Several studies largely demonstrated the usefulness of implementing DWI/ADC MRI in the characterization of breast lesions. Herein, in the light of our clinical experience, we perform a review of the literature regarding the diagnostic performance and accuracy of ADC value as potential pre-operative tool to define metastatic involvement of nodal structures in breast cancer patients. For the purpose of this review, PubMed, Web of Science, and SCOPUS electronic databases were searched with different combinations of "axillary lymph node", "breast cancer", "MRI/ADC", "breast MRI" keywords. All original articles, reviews and metanalyses were included.

Indexed as

apparent diffusion coefficient magnetic resonance imaging (ADC-MRI)axillary lymph nodesBreast cancerdiffusion-weighted imaging (DWI)metastases

Identifiers

PMID33447575
PMCPMC7804544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.